Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.6065/apem.2013.18.1.13 http://scihub22266oqcxt.onion/10.6065/apem.2013.18.1.13 C4027066!4027066!24904845     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Pediatr+Endocrinol+Metab 2013 ; 18 (1): 13-8 Nephropedia Template TP {{tp|p=24904845|t=2013. Response to three years of growth hormone therapy in girls with Turner syndrome |pdf=|usr=}}{{24904845}} gab.com Text Response to three years of growth hormone therapy in girls with Turner syndrome JO: Ann Pediatr Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=24904845 #FOAvip Purpose: Short stature is the most common finding in patients with Turner syndrome. Improving the final adult height in these patients is a challenge both for the patients and physicians. We investigated the clinical response of patients to growth hormone treatment for height improvement over the period of three years. Methods: Review of medical records from 27 patients with Turner syndrome treated with recombinant human growth hormone for more than 3 years was done. Differences in the changes of height standard deviation scores according to karyotype were measured and factors influencing the height changes were analyzed. Results: The response to recombinant human growth hormone was an increase in the height of the subjects to a mean value of 1.1 standard deviation for subjects with Turner syndrome at the end of the 3-year treatment. The height increment in the first year was highest. The height standard deviation score in the third year was negatively correlated with the age at the beginning of the recombinant human growth hormone treatment. Different karyotypes in subjects did not seem to affect the height changes. Conclusion: Early growth hormone administration in subjects with Turner syndrome is helpful to improve height response to the treatment. Twit Text FOAVip Response to three years of growth hormone therapy in girls with Turner syndrome ????Ann Pediatr Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=24904845 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24904845 #FOAvip English Wikipedia <ref>{{Cite pmid|24904845}}</ref> Response to three years of growth hormone therapy in girls with Turner syndrome #MMPMID24904845 Park HK; Lee HS; Ko JH; Hwang IT; Hwang JS Ann Pediatr Endocrinol Metab 2013[Mar]; 18 (1): 13-8 PMID24904845show ga Purpose: Short stature is the most common finding in patients with Turner syndrome. Improving the final adult height in these patients is a challenge both for the patients and physicians. We investigated the clinical response of patients to growth hormone treatment for height improvement over the period of three years. Methods: Review of medical records from 27 patients with Turner syndrome treated with recombinant human growth hormone for more than 3 years was done. Differences in the changes of height standard deviation scores according to karyotype were measured and factors influencing the height changes were analyzed. Results: The response to recombinant human growth hormone was an increase in the height of the subjects to a mean value of 1.1 standard deviation for subjects with Turner syndrome at the end of the 3-year treatment. The height increment in the first year was highest. The height standard deviation score in the third year was negatively correlated with the age at the beginning of the recombinant human growth hormone treatment. Different karyotypes in subjects did not seem to affect the height changes. Conclusion: Early growth hormone administration in subjects with Turner syndrome is helpful to improve height response to the treatment. äResponse to three years of growth hormone therapy in girls with Turner(epmc).pdf DeepDyve Pubget Overpricing